New CRISPR Technology Offers Unrivaled Control of Epigenetic Inheritance

Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome – proteins and small molecules that latch onto DNA and control when and where genes are switched on or off. In a paper published April 9, 2021, in the

Pancreatic Cancer Cells Hijack Muscle Protein to Beef Up Their Metabolism

Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows. “A major obstacle cancer cells must overcome is their incessant need

Allan Balmain Elected Fellow of the AACR Academy

Allan Balmain, PhD, FRS has been named to the 2021 class of fellows of the American Association for Cancer Research (AACR) Academy. Dr. Balmain holds the Barbara Bass Bakar Distinguished Professorship in Cancer Genetics at the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC). Allan

Current and Future Applications of 3D Printing in Breast Cancer Management

3D printing technology has been around for about 40 years. In medicine, we have seen rapid expansion across almost every subspecialty from pre-surgical planning to production of patient-specific surgical devices to simulation and training. However, there is a notable lack of literature on the

How Inequities Fueled the COVID-19 Pandemic – And What We Can Do About It

Inspiration and Determination Mark COVID Anniversary

New Computational Cancer Community (C3) Provides Forum for Feedback, Collaborations

The Computational Cancer Community (C3) was recently created to provide a forum for labs focused on cancer genomics and computational cancer biology and oncology to share their work and to get feedback and input. Below, steering committee member Franklin Huang, MD, PhD, offers further details about